Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer

As a clinically heterogeneous subtype of breast cancer, triple-negative breast cancer (TNBC) is associated with a poor clinical outcome and a high relapse rate. Conventional chemotherapy and radiotherapy are effective treatments for patients with TNBC. However, the prognosis of TNBC remains unsatisf...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncol Lett
Egile Nagusiak: Wu, Nan, Zhang, Jinghua, Zhao, Jing, Mu, Kun, Zhang, Jun, Jin, Zhao, Yu, Jinpu, Liu, Juntian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2018
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144355/
https://ncbi.nlm.nih.gov/pubmed/30250564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9290
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak